Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AF Patient Preferences Towards NOAC Versus VKA Treatment: a Patient Preference Study.

NCT02611635 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02611635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02611635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AF Patient Preferences Towards NOAC Versus VKA Treatment: a Patient Preference Study.
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
February 2, 2016
Completion date
February 16, 2017
Enrollment
382 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation